In 2022, Merck generated sales of more than 20 billion euros for the first time.
(Photo: dpa [M])
Frankfurt The Darmstadt-based Merck Group is one of the big climbers in the German chemical and pharmaceutical industry. He has cemented that role over the past year. Merck not only achieved double-digit growth in sales and exceeded the 20 billion euro mark for the first time. The family company was also able to increase earnings despite rising costs.
CEO Belén Garijo can present shareholders at the annual general meeting on Friday with a statement that underpins the resilience of the group. The focus on pharmaceuticals, life sciences and electronic chemicals continues to pay off for Merck.
But the Handelsblatt balance sheet check shows that the air for further growth is getting thinner for Merck. In the past three years, the group has benefited from a number of special factors that are now weakening or turning into the opposite. These include the corona pandemic, the boom in the electronics industry and the strong appreciation of the dollar in 2022.
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further
Read on now
Get access to this and every other article in the
web and in our app.
Further